Pharmaceutical industry news

FDA extends review of Exelixis drug application for metastatic colorectal cancer

Profitable Biotech Incyte Forms Handle As Institutional Buyers Load Up On Stock

Transition of the Icelandic Medicines Agency’s Website in Full Swing

mRNA cancer vaccines’ biggest barriers to market

U.S. FDA extends review of Exelixis’ cancer drug

ANMAT evaluó y liberó más de 430 lotes de vacunas entre junio de 2025 y mayo de 2026

FDA Extends Review Timeline for Exelixis Cancer Drug

Frost & Sullivan presents the "GLOBAL GENE THERAPY CRDMO TECHNOLOGY INNOVATION LEADERSHIP AWARD" to PackGene Biotech Inc.

Biohaven’s epilepsy drug hit with FDA clinical hold

How Investors May Respond To SELLAS Life Sciences Group (SLS) Phase 3 Trial Nears

The Early Scale: CPC Biotech and Multiply Labs smoothen cell therapy automation bottleneck

Shanghai Henlius Biotech Says NDA For 120 Mg Biosimilar Denosumab HLX14 Accepted By NMPA

MRKON Risks Explained: KEYTRUDA Dependence, Patent Expiry, Clinical Trials and Tokenized Stock Risk

Poland's case against EU wastewater rules boosted by Advocate General opinion

Angelman drug partner for Research Alliance III (RACC) eyes 2029 data

Estates Safety Fund: initial schemes and associated funding allocations, 2026 to 2030

A list of funding allocations from the Estates Safety Fund to address critical infrastructure and sa...

Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September

AstraZeneca shares phase 3 results for Imfinzi plus Imdelltra in extensive-stage small cell lung cancer

From Tartan Army to biotech – deepening Scotland’s ties with Boston through new life sciences partnership

AZ’s COPD drug cuts flare-ups in two phase 3 trials

Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September

Head of German venture fund sees big potential in Danish biotech – but investors are lacking

Are you working with the non-clinical package for clinical trial applications? See Q&A-update!

Rewriting the rules of genetic medicine with tRNA therapeutics｜Beyond Biotech

Trial misses prompt shake-up call from major Novartis stockholder

What regulators ask when AI touches a drug application

Key approvals, positive study results and a partnership deal to fast track new medications

Shanghai Henlius Biotech, Inc. Announces Acceptance Of New Drug Application For 120 Mg (1.7 Ml) Per Vial Strength Of Biosimilar Of Denosumab HLX14

AbbVie drug meets phase 3 goal in menstrual migraine

Meet the under-35s shaping the future of biotech

Aprecia Pharmaceuticals: 'AM is an important expansion of the pharmaceutical manufacturing toolbox'

Anavex Life Sciences to discuss pediatric inclusion in Rett syndrome trial By Investing.com

Biotech for Climate Resilience Fund

Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak

FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?

[Reporter’s Notebook] K-biopharma licensing deals are getting better, not just bigger

Weekly all-cause mortality surveillance: week ending 13 September 2026

How the actual number of deaths in England compare with expected numbers for each week.

Astadaily earns Purity Award from Clean Label Project

JPMorgan initiates Dianthus stock at Overweight, $135 target

[Reporter’s Notebook] K-biopharma licensing deals are getting better, not just bigger

Biotech students must step out of comfort zones, embrace multiple roles: Suchitra Ella

FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer

Limitless Biotech Coupon Code PCT15: Save 15% on Research Peptides

Kenanga launches world first Hang Seng Biotech Index structured warrants

Marquis Who's Who Honors Kenneth Hesterman for Expertise in Pharmaceutical Account Management

Pharmaceutical Excipients Market to reach USD 24.88 Billion by 2035 at 8.1% CAGR

Velocity Clinical, Stitch expand partnership across 70+ sites to boost screening attendance

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal

Phase 3 study shows aQIVc superior to comparators in older adults

REG - RTW Biotech Opp. - Additional investment in Encoded Therapeutics

ORZEYFUL Approval Might Change The Case For Investing In Takeda Stock

What Strong Biotech IP Strategies Get Right And Where Weak Ones Break Down

Comment: Climate change threatens pharmaceutical companies

Henlius

Former head of Takeda Pharmaceutical dies at 80

Active Biotech AB (publ) (STO:ACTI): Is Breakeven Near?

FDA partially halts trials of SK Biopharmaceuticals’ epilepsy drug candidate

West Pharmaceutical Services senior VP favorite sells $2.77m in stock

Jiangsu Handian Biotech lands tens of millions of yuan in strategic round

Ex-Takeda Pharmaceutical Head Hasegawa Dies at 80